BRD2 and polycystic ovary syndrome: Stimulated gonadotropin-releasing hormone and improved hormonal balance. Enhanced the level of IFN-γ, IL-2, and GM-CSF in mice. Increased the FSH and decreases LH, testosterone, and estradiol in letrozole-induced PCOS rats.